Gretchen E Tietjen
Overview
Explore the profile of Gretchen E Tietjen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
938
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dafer R, Tietjen G, Rothrock J, Vann R, Shrewsbury S, Aurora S
Headache
. 2024 May;
64(8):983-994.
PMID: 38800847
Objective: To report the cardiovascular (CV) safety of dihydroergotamine mesylate (DHE) administered by precision olfactory delivery (INP104) from two clinical trials. Background: Although the absolute risk is low, migraine is...
2.
3.
4.
Lipton R, Buse D, Nahas S, Tietjen G, Martin V, Lof E, et al.
J Neurol
. 2023 Aug;
270(12):5692-5710.
PMID: 37615752
Background: In individuals with migraine, attacks may increase in frequency, severity, or both. Preventing migraine progression has emerged as a treatment goal in headache subspecialty practice, but there may be...
5.
Gonzalez N, Amin-Hanjani S, Bang O, Coffey C, Du R, Fierstra J, et al.
Stroke
. 2023 Aug;
54(10):e465-e479.
PMID: 37609846
Adult moyamoya disease and syndrome are rare disorders with significant morbidity and mortality. A writing group of experts was selected to conduct a literature search, summarize the current knowledge on...
6.
7.
Chiang C, Shahid A, Harriott A, Tietjen G, Savastano L, Klaas J, et al.
Cephalalgia
. 2021 Nov;
42(6):542-552.
PMID: 34786968
Background: Headache in patients with moyamoya disease is an under-addressed topic in the medical literature. Delay in the diagnosis of moyamoya disease or inappropriate treatment of headache could lead to...
8.
Smitherman T, Tietjen G, Schuh K, Skljarevski V, Lipsius S, DSouza D, et al.
Headache
. 2020 Oct;
60(10):2202-2219.
PMID: 33063862
Objective: This post hoc analysis evaluated the efficacy of galcanezumab for the prevention of migraine in patients with and without comorbid anxiety and/or depression. Background: Patients with migraine have a...
9.
10.
Tietjen G, Maly E
Headache
. 2020 Apr;
60(5):843-863.
PMID: 32246455
Objective/background: Migraine is associated with ischemic stroke. Women are 3-fold as likely as men to have migraine, and high estrogen states increase the risk of migraine with aura (MWA), venous...